Navigation Links
Filtrona Porous Technologies Realizes Innovative New Product Development Through Foam-Fiber Technology Synergy : Introducing MediSponge(R) RBR Wound Care Dressings
Date:11/4/2009

RICHMOND, Va., Nov. 4 /PRNewswire-FirstCall/ -- Filtrona Porous Technologies, manufacturer of custom fluid handling fiber and foam components for the medical device and healthcare industry, and a division of UK-based Filtrona plc (Pink Sheets: FLRAF), has recently developed a unique foam-fiber hybrid component for select medical and personal care markets, specifically wound care. Referred to as MediSponge® RBR, the patent-pending foam-fiber composite consists of a soft, highly absorbent foam with hydrophilic properties structurally enhanced by the addition of a fiber matrix. The development represents yet another innovation by Filtrona Porous Technologies in the area of specialty healthcare industry products.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081017/NEF038LOGO )

Hydrophilic foam's presence as a wound dressing material has increased dramatically the last several years, featuring prominently in select advanced wound care settings. MediSponge RBR now expands the technology's application range within this market. To date, one delimiting characteristic of hydrophilic foam is its tensile and structural strength when wet, especially when exposed to moist or damp conditions for a substantial period of time. This consideration has mitigated the media's full potential with longer-term, advanced wound applications desirous of reduced dressing changes, even including, when combined with its expansive properties, some negative pressure therapy environments.

Filtrona's new MediSponge RBR overcomes these limitations. MediSponge RBR incorporates to the foam media a fiber matrix that acts as a reinforcement or rebar-like structural enhancement. Versus the standard wet hydrophilic foam material, the average tensile strength, tear strength, and expansion properties may be improved by as much as 600 times, 40 time
'/>"/>

SOURCE Filtrona Porous Technologies
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy
2. Leading Event for People With Disabilities on November 6-8 Features Latest Technologies, Products, Services, and More
3. Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies and Markets
4. China Medical Technologies to Hold its Annual General Meeting on November 16, 2009
5. Palatin Technologies to Present at 8th Annual BIO Investor Forum
6. Wound Management Technologies (OTCBB- WNDM) Signs Biotech Agreement With Biocure S.r.l. of Milan, Italy
7. BioStorage Technologies, Inc., Accelerates European Expansion with Opening of New German Facility
8. Timm Medical Technologies and Ferring Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Prosed(R) DS
9. Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington, D.C.
10. Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference
11. Noninvasive Medical Technologies Awarded ISO 13485 Quality Certification

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...swire/ -- CCS Medical, Inc. a leading direct-to-co...ed that it has received approval from the United S...he "Court") for its bidding procedures in connecti...tially all of its assets. ,, Pursuant to an Ord...ding procedures for the sale of substantially all ...
(Date:12/1/2009)...rstCall/ -- CryoLife, Inc. ( CRY) , an implantabl...sue processing company, announced its initial fina... total revenues for the full year of 2010 to be be...ludes between $1.5 million and $2.5 million relate...se in connection with the development of BioFoam. ...
(Date:12/1/2009)...RNewswire/ -- Siemens Hearing Instruments, Inc., ...nufacturer of hearing instruments, announced its t... Sound Beginnings program. The alliance will be ef...he renewed partnership, Siemens is expanding the p...struments to both children and young adults, age 2...
Breaking Medicine Technology:CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2CryoLife Provides Initial 2010 Financial Guidance 2CryoLife Provides Initial 2010 Financial Guidance 3CryoLife Provides Initial 2010 Financial Guidance 4CryoLife Provides Initial 2010 Financial Guidance 5Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 3Anxious Kids at Risk for Obesity in Adulthood 57251 1Anxious Kids at Risk for Obesity in Adulthood 57251 2Young Adults with Cancer Focus of Program Developed by Providence Saint Joseph Medical Center and Childrens Hospital Los Angeles 57247 1Young Adults with Cancer Focus of Program Developed by Providence Saint Joseph Medical Center and Childrens Hospital Los Angeles 57247 2Young Adults with Cancer Focus of Program Developed by Providence Saint Joseph Medical Center and Childrens Hospital Los Angeles 57247 3Insurance and HMO Industries Spend Nearly 24700 000 Per Day to Kill Health Care Reform Measures 57243 1Insurance and HMO Industries Spend Nearly 24700 000 Per Day to Kill Health Care Reform Measures 57243 2
...vember 21 , - Not for UK Journalists , ...r Human Use (CHMP) today,announced its positive re...cept) as a treatment for children aged 8 years and.... If approved by the European,Commission, followin...me the,first biologic treatment indicated for seve...
...ADELPHIA, Nov. 20 GlaxoSmithKline (NYSE: GSK ) t...g Administration (FDA) granted accelerated approva...of thrombocytopenia in patients with chronic immun...have had an insufficient response to corticosteroi...s a significant milestone for PROMACTA and the ITP...
Other Medicine Technology:CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 2CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 3CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 4CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8
(Date:12/1/2009)..., , MIAMI, FL (December 1, 2009)The Clinical Rese...ller School of Medicine, has been honored for its ...d the LEED designation, established by the U.S. Gr...lding Certification Institute (GBCI). LEED is the ...uction and operation of green buildings., "Having...
(Date:12/1/2009)..., , SMITHFIELD, R.I., De...tective equipment, bad assumptions are hazardous a...25 years of government regulation, a handful of pe...ring both the effectiveness of occupational Heari...ring. ,, A new free, white paper from Howard L...
(Date:12/1/2009)..., , WASHINGTON, Dec. 1 /PRNewswire-USNewsw.... Agency for International Development: ,, Chai...he Committee. ,, I am honored to be nominated b... United States Agency for International Developmen...he Agency. ,, Secretary of State Clinton has e...
(Date:12/1/2009)..., Barcelona, 30 November 2009. Performing surgic...be a chimera and has become a reality. This is dem...ng NOTES (Natural Orifice Transluminal Endoscopy S...ws surgical access using the body,s natural orific...nt: lack of scars, shorter hospital stay and faste...
(Date:12/1/2009)..., Montreal, December 1, 2009 A Universit de Mont...search Center on Family Violence and Violence Agai... effects of pornography on men. "We started our re... consumed pornography. We couldn,t find any," says...d professor at the School of Social Work. , "Th...
Breaking Medicine News(10 mins):Health News:UM Clinical Research Building awarded prestigious LEED Building Certification 2Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 2Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 2Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 4Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 5Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 6Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 7Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 8Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 9Health News:Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus 2Health News:Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus 3Health News:Are the effects of pornography negligible? 2
...ill, arsenic also can prolong the lives of patient...aturday found. "This study shows that even...arlier in the course of treatment," said Dr. Bayar...erican Society of Oncology (ASCO) which brought to...
...JAMA, has identified novel genetic mutations linke... that these mutations are due to both independent ...as been released early to coincide with its presen...is the second most common cause of cancer death wo...
...sburgh Medical Center (UPMC) study presented at th...al Oncology (ASCO) in Chicago and published as Abs...ted for follicular lymphoma, a slow-growing type o...to the treatment and since only a short-course of ...
...nounced follow-up data from a Phase 2 clinical tri...ch was conducted by the Johns Hopkins Sidney Kimme...ith operable pancreatic cancer who received GVAX a... to be 26.8 months, a result which compares favora...
...end, even if it is all subtle, as in Canada appare...e hard to pin down is more dangerous to mental hea...dy of 180 Korean immigrants living in Canada. ...lead author Samuel Noh, professor of psychiatry at...
...g of SNM, the world's largest society for molecula...man researchers stated that early metabolic imagin...ely identifies patients responding to chemotherapy...the treatment of common solid tumors," said Ken He...
Other Medicine News:Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 2Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 3Health News:Lymphoma Patients Maybe Helped by Adding Radioimmunotherapy to Chemo 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 3Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 4Health News:Koreans in Canada Feel Put Down by Subtle Racism 2Health News:Esophageal Cancer Patients' Positive Responses to Chemotherapy Accurately Identified by PET 2
Lacrimal Cannula, Curved - Open End.
PremierEdge™ Implant Knives
Universal I/A handpiece - Titanium (Binkhorst Tip)
Universal I/A handpiece - Titanium (Curved Tip, Size: 16g Outer Cannula)
Medicine Products: